Latest Receptos Inc. Stories
New Clinical Trial Data: Scripps Research Institute MS Drug Candidate Also Shows Promise for Ulcerative Colitis
LA JOLLA, Calif., and JUPITER, Fla., Oct.
Initiation of Clinical Trials, Completed Acquisitions, Financial Results, and Earnings Release Schedules - Analyst Notes on Cell Therapeutics, Intrexon, Chimerix, Receptos, and Revance Therapeutics
Editor Note: For more information about this release, please scroll to bottom. NEW YORK, March 18, 2014 /PRNewswire/ -- Today, Analysts Review released its analysts'